SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-276774
Filing Date
2021-09-20
Accepted
2021-09-20 08:06:31
Documents
12
Period of Report
2021-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K d215432d8k.htm   iXBRL 8-K 31127
  Complete submission text file 0001193125-21-276774.txt   159789

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA phat-20210917.xsd EX-101.SCH 2907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20210917_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20210917_pre.xml EX-101.PRE 11870
5 EXTRACTED XBRL INSTANCE DOCUMENT d215432d8k_htm.xml XML 3482
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 211262084
SIC: 2834 Pharmaceutical Preparations